DK0861068T3 - Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse - Google Patents

Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse

Info

Publication number
DK0861068T3
DK0861068T3 DK96938066T DK96938066T DK0861068T3 DK 0861068 T3 DK0861068 T3 DK 0861068T3 DK 96938066 T DK96938066 T DK 96938066T DK 96938066 T DK96938066 T DK 96938066T DK 0861068 T3 DK0861068 T3 DK 0861068T3
Authority
DK
Denmark
Prior art keywords
homogenizer
bar
drug
preparing
predispersion
Prior art date
Application number
DK96938066T
Other languages
Danish (da)
English (en)
Inventor
Bernd Klinksiek
Said Mahiout
Ricarda-Christine Nothelle
Hans-Juergen Hamann
Juergen Sdebik
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0861068T3 publication Critical patent/DK0861068T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/46—Homogenising or emulsifying nozzles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/70—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming
    • B01F33/71—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming working at super-atmospheric pressure, e.g. in pressurised vessels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96938066T 1995-11-15 1996-11-04 Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse DK0861068T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19542499A DE19542499A1 (de) 1995-11-15 1995-11-15 Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
PCT/EP1996/004795 WO1997017946A2 (de) 1995-11-15 1996-11-04 Verfahren und vorrichtung zur herstellung einer parenteralen arzneistoff-zubereitung

Publications (1)

Publication Number Publication Date
DK0861068T3 true DK0861068T3 (da) 2002-12-02

Family

ID=7777475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96938066T DK0861068T3 (da) 1995-11-15 1996-11-04 Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse

Country Status (11)

Country Link
US (1) US6331314B1 (OSRAM)
EP (1) EP0861068B1 (OSRAM)
JP (1) JP4049391B2 (OSRAM)
AT (1) ATE222097T1 (OSRAM)
CA (1) CA2237554C (OSRAM)
DE (2) DE19542499A1 (OSRAM)
DK (1) DK0861068T3 (OSRAM)
ES (1) ES2180807T3 (OSRAM)
MX (1) MX9803633A (OSRAM)
PT (1) PT861068E (OSRAM)
WO (1) WO1997017946A2 (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69915434T2 (de) 1998-12-07 2005-03-03 Dsm Ip Assets B.V. Verfahren und Vorrichtung zum Mischen oder Dispergieren von Flüssigkeiten
US20020119188A1 (en) * 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
EP1222957A1 (en) * 2000-12-22 2002-07-17 Société des Produits Nestlé S.A. Process and device for producing a food grade oil-in-water emulsion
DE102004055507A1 (de) * 2004-11-17 2006-05-18 Basf Ag Verfahren zur Herstellung feinteiliger flüssig-flüssig Formulierungen und Vorrichtung zur Herstellung feinteiliger flüssig-flüssig Formulierungen
WO2007111937A1 (en) * 2006-03-23 2007-10-04 Applera Corporation Directed enrichment of genomic dna for high-throughput sequencing
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US7491856B2 (en) * 2007-06-27 2009-02-17 H R D Corporation Method of making alkylene glycols
US7479576B1 (en) * 2007-06-27 2009-01-20 H R D Corporation Method of hydrogenating aldehydes and ketones
US8304584B2 (en) * 2007-06-27 2012-11-06 H R D Corporation Method of making alkylene glycols
US7652175B2 (en) * 2007-06-27 2010-01-26 H R D Corporation High shear process for the production of acetaldehyde
PL2158028T3 (pl) * 2007-06-28 2013-04-30 Procter & Gamble Urządzenie i sposób mieszania poprzez wytworzenie ścinania i kawitacji w płynie
US8322910B2 (en) 2008-07-25 2012-12-04 The Procter & Gamble Company Apparatus and method for mixing by producing shear and/or cavitation, and components for apparatus
CN101617990B (zh) * 2009-07-31 2013-01-23 中国人民解放军第三军医大学 脂质体制备装置以及使用该装置制备脂质体的方法
JP5771366B2 (ja) * 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
EA025622B1 (ru) 2009-12-03 2017-01-30 Новартис Аг Способ получения содержащей сквален эмульсии масла
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
MX2012006216A (es) 2009-12-03 2012-07-12 Novartis Ag Circulacion de componentes durante la homogenizacion de emulsiones.
DE102009056884B4 (de) * 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP4651984A1 (en) * 2023-01-17 2025-11-26 DSM IP Assets B.V. Liquid dispersion preparation processes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
EP0082877A1 (en) * 1981-07-06 1983-07-06 Rush-Presbyterian-St.Luke's Medical Center Preparation of synthetic erythrocytes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
DE3515335C2 (de) 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
CA2146963A1 (en) * 1992-10-16 1994-04-28 Andreas Sachse Process and device for producing liquid, dispersed systems
DE4328331A1 (de) * 1993-08-18 1995-02-23 Andreas Dr Sachse Kontinuierliches Hochdruckextrusionsverfahren zur Herstellung von Liposomen und Emulsionen

Also Published As

Publication number Publication date
EP0861068B1 (de) 2002-08-14
CA2237554C (en) 2007-01-09
PT861068E (pt) 2002-12-31
CA2237554A1 (en) 1997-05-22
MX9803633A (es) 1998-09-30
WO1997017946A3 (de) 1997-09-12
DE59609564D1 (de) 2002-09-19
JP2000500146A (ja) 2000-01-11
ATE222097T1 (de) 2002-08-15
WO1997017946A2 (de) 1997-05-22
US6331314B1 (en) 2001-12-18
ES2180807T3 (es) 2003-02-16
DE19542499A1 (de) 1997-05-22
EP0861068A2 (de) 1998-09-02
JP4049391B2 (ja) 2008-02-20

Similar Documents

Publication Publication Date Title
DK0861068T3 (da) Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse
WO2001036018A3 (en) Method and apparatus for relieving ailments using gases to increase the effectiveness of drugs
TW347339B (en) Oral delivery of discrete units
MX9602515A (es) Procedimiento para preparar formas de dosis farmaceuticas de substancias hidrofobicas.
EP0833614A4 (en) SYSTEM AND METHOD FOR PRODUCING MEDICINE-LOADED MICROPARTICLES
EP0711127A4 (en) METHOD FOR PREPARING LIPOSOMES WITH GAS INCLUDED
DE69505677D1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
ATE189403T1 (de) Vorrichtung zum verabreichen von pharmazeutischen substanzen
GR3034167T3 (en) Therapeutic agent for the treatment of melanomas
IL140848A0 (en) Treatment regimen for administration of phenylacetylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
ATE289801T1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
IL150528A0 (en) Ibuprofen containing active agent preparation
ATE269057T1 (de) Arzneizubereitungen und deren herstellungsverfahren
AU5658196A (en) Method for pharmaceutical delivery
EP1767230A3 (en) Apparatus and method for blood oxygenation
DK0804175T3 (da) Fremgangsmåde og anordning til fremstilling af en fladeformet indgivelsesform med et præparat, der indeholder aktive lægemi
AU2001239625A1 (en) Method of preparing solid dispersions
MY100780A (en) Azumolene dosage form.
NO20000621D0 (no) FremgangsmÕte for fremstilling av kontrastmiddel
De Leede et al. Rectal infusion of the model drug antipyrine with an osmotic delivery system
TR200001671T2 (tr) L-Dihidroorotik asit elde etmek için işlem ve kullanımı.
De Mey et al. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction
EP1288311A3 (en) Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells
SE9901059L (sv) Metod för framställning av partiklar
WO2025019429A3 (en) Apparatus, methods, and systems for delivery and administration of pharmaceutical, therapeutic and cosmetic substances to users